Invivoscribe Technologies, Inc.

Industry

  • Services
    • Group Purchasing
    • Home Infusion
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • Pharmaceuticals

Other Names/Subsidiaries

  • LabPMM
See more in Biomedtracker

Latest on Invivoscribe Technologies, Inc.

Scrip

Deal Watch: Ovid Teams With Gensaic On Phage-Derived, Gene-Delivered Therapies

 
• By Joseph Haas and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Ovid Taps Gensaic’s Approach To Neurolo

Scrip

Deal Watch: Roche Partners With Jnana On Cellular Metabolism Approach To Disease

 
• By Joseph Haas

Roche Pays $40m Up Front In Pact With Jnana Roche Holding AG agreed to pay $40m up front on 21 July under a partnership with Jnana Therapeutics Inc. centered on targeting solute carrier (SLC) prot

Medtech Insight

Molecular Dx Exec Named New US FDA Diagnostics Chief

 
• By David Filmore

Timothy Stenzel has been spending his time helping lead development of new companion diagnostics and next-generation sequencing panels. Now he will be the point person for regulating these products in

Medtech Insight

US Approvals Analysis: April A Big Month For Non-Invasive Neurostim

 
• By David Filmore

[ Editors' note: For sortable and searchable tables of US and international approvals and clearances check out our Approvals Tracker . ] R&D into non-invasive neurostimulation devices, a market a